このエントリーをはてなブックマークに追加
ID 47010
JaLCDOI
フルテキストURL
Thumnail 65_5_287.pdf 6.38 MB
著者
Hiraki, Takao Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Gobara, Hideo Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Mimura, Hidefumi Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Toyooka, Shinichi Department of Cancer and Thoracic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Fujiwara, Hiroyasu Department of Diagnostic Radiology, National Cancer Center Hospital
Yasui, Kotaro Department of Radiology, Okayama Saiseikai General Hospital
Sano, Yoshifumi Department of Thoracic Surgery, Ehime University Hospital
Iguchi, Toshihiro Department of Diagnostic Radiology and Interventional Radiology, Fukuyama City Hospital
Sakurai, Jun Department of Radiology, Kagawa Prefectural Central Hospital
Tajiri, Nobuhisa Department of Radiology, Mitoyo General Hospital
Mukai, Takashi Department of Radiology, Okayama Medical Center
Matsui, Yusuke Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kanazawa, Susumu Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
抄録
The application of radiofrequency ablation for the treatment of lung cancer by our group at Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences began in June 2001, and in the present report, we review our 10-year experience with this treatment modality at Okayama University Hospital. The local efficacy of radiofrequency ablation for the treatment of lung cancer depends on tumor size and the type of electrode used, but not on tumor type. An important factor for the prevention of local failure may be the acquisition of an adequate ablative margin. The combination of embolization and radiation therapy enhances the local efficacy. Local failure may be salvaged by repeating the radiofrequency ablation, particularly in small tumors. Survival rates after radiofrequency ablation are quite promising for patients with clinical stage I non-small cell lung cancer and pulmonary metastasis from colorectal cancer, hepatocellular carcinoma, and renal cell carcinoma. The complications caused by radiofrequency ablation can be treated conservatively in the majority of cases. However, attention should be paid to rare but serious complications. This review shows that radiofrequency ablation is a promising treatment for patients with lung cancer.
キーワード
radiofrequency ablation
lung cancer
local efficacy
survival
complication
Amo Type
Review
発行日
2011-10
出版物タイトル
Acta Medica Okayama
65巻
5号
出版者
Okayama University Medical School
開始ページ
287
終了ページ
297
ISSN
0386-300X
NCID
AA00508441
資料タイプ
学術雑誌論文
言語
English
著作権者
CopyrightⒸ 2011 by Okayama University Medical School
論文のバージョン
publisher
査読
有り
PubMed ID
Web of Sience KeyUT